Georgia Erbez
Director/Board Member at COHERUS BIOSCIENCES, INC.
Net worth: 225 271 $ as of 2024-02-28
Profile
Georgia L.
Erbez is the founder of Beal Advisors LLC, which was founded in 2008.
She is currently a Director at Coherus BioSciences, Inc. and Neurana Pharmaceuticals, Inc. Ms. Erbez has held former positions as a Director at Cowen & Co. LLC, an Independent Director at Sierra Oncology, Inc., Artelo Biosciences, Inc., and Asterias Biotherapeutics, Inc. She was also a Managing Director at Collins Stewart LLC, Axiom Financial Partners, and Jefferies LLC.
Ms. Erbez served as CFO, Secretary & Treasurer at Raptor Pharmaceuticals Corp.
and Horizon Pharmaceutical LLC.
She was also the Chief Financial & Business Officer at Zosano Pharma Corp.
and the Chief Financial Officer & Senior Vice President at Revolution Medicines, Inc. Ms. Erbez was the Chief Financial Officer & Secretary at Harpoon Therapeutics, Inc. from 2018 to 2022.
She was also the Chief Operating Officer at Walking Fish Therapeutics, Inc. from 2022 to 2023.
Ms. Erbez received her undergraduate degree from the University of California, Davis in 1989.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-06 | 9,820 ( 0.05% ) | 225 271 $ | 2024-02-28 | |
2024-02-19 | 0 ( -.--% ) | - $ | 2024-03-30 |
Georgia Erbez active positions
Companies | Position | Start |
---|---|---|
COHERUS BIOSCIENCES, INC. | Director/Board Member | 2024-02-19 |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Director/Board Member | 2021-05-31 |
Former positions of Georgia Erbez
Companies | Position | End |
---|---|---|
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Chief Operating Officer | 2023-09-30 |
HARPOON THERAPEUTICS, INC. | Director of Finance/CFO | 2022-08-30 |
SIERRA ONCOLOGY, INC. | Director/Board Member | 2022-06-30 |
ARTELO BIOSCIENCES, INC. | Director/Board Member | 2019-12-01 |
Axiom Financial Partners | Corporate Officer/Principal | 2018-09-30 |
Training of Georgia Erbez
University of California, Davis | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ARTELO BIOSCIENCES, INC. | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
HARPOON THERAPEUTICS, INC. | Health Technology |
Private companies | 13 |
---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Finance |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Beal Advisors LLC
Beal Advisors LLC Investment ManagersFinance Beal Advisors LLC provides investment advice services. The private company is based in Walnut Creek, CA. The company was founded by Georgia L. Erbez. | Finance |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
Axiom Financial Partners | |
Altibio, Inc. | |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Health Technology |
Collins Stewart LLC
Collins Stewart LLC Investment Banks/BrokersFinance Founded in 1991, Collins Stewart LLC is a broker/dealer headquartered in New York City. The firm is a subsidiary of UK-based Collins Stewart Plc. Their research focuses on the aerospace and defense, technology, telecommunications, biotechnology, Internet/software and semiconductors sectors | Finance |
Zosano Pharma Corp.
Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Georgia Erbez